Publication: Vectorización por control extracorpóreo
Loading...
Official URL
Full text at PDC
Publication Date
2016-06
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
El proceso de vectorización supone la liberación del fármaco una vez que el vector llega a biofase. El uso de un campo magnético externo permite la vectorización de nanopartículas magnéticas funcionalizadas y su acumulación en tejidos tumorales. Gracias a sus propiedades pueden dar lugar al efecto de hipertermia, que ocasiona la destrucción selectiva de las células cancerosas. Todo ello permite la reducción de efectos adversos y el incremento de la eficacia del tratamiento antitumoral.
Drug targeting processes enable the release of the drug once the carrier is in biophase. Functionalized magnetic nanoparticles can be delivered to cancer tissues by means of an external magnetic field. Due to their properties hyperthermia effect can take place, causing the selective destruction of cancer cells. As a result, adverse effects decrease while the efficacy of the anticancer treatment increases.
Drug targeting processes enable the release of the drug once the carrier is in biophase. Functionalized magnetic nanoparticles can be delivered to cancer tissues by means of an external magnetic field. Due to their properties hyperthermia effect can take place, causing the selective destruction of cancer cells. As a result, adverse effects decrease while the efficacy of the anticancer treatment increases.